Effectiveness of three nasoenteral tube securement technologies in critically ill adults: A pragmatic cluster-randomized crossover trial.
文献摘要
Background Nasoenteral tube stability is essential for the success of enteral nutritional therapy in critically ill patients. However, comparative evidence regarding the effectiveness and safety of available securement technologies remains limited, particularly concerning the balance between tube stability and preservation of skin and mucosal integrity. Objective To compare the effectiveness and safety of three nasoenteral tube securement technologies in critically ill patients. Design A pragmatic, cluster-randomized, crossover, controlled, superiority, triple-blind clinical trial. Settings The study was conducted in intensive care units at three large Brazilian hospitals. Participants A total of 217 patients were included and received one of three securement strategies according to their intensive care unit-period allocation: manufactured securement using acrylate adhesive tape (control; n =75), a dedicated device with acrylate adhesive ( n =72), or a dedicated hydrocolloid-based device ( n =70). Methods The participants were prospectively monitored during nasoenteral tube use. Outcomes included tube displacement and inadvertent removal, securement durability, device-related skin and mucosal injuries, and interruption of enteral nutritional therapy. Comparisons between groups were performed using generalized linear mixed models and survival analysis. Results No statistically significant differences were observed among the groups regarding nasoenteral tube displacement or inadvertent removal. The hydrocolloid group showed a higher risk of securement failure compared to the control group (hazard ratio=1.93; 95% confidence interval: 1.28-2.90; p =0.002) but a lower incidence of medical adhesive-related skin injury (7.1%) than the control group (34.7%) and the acrylate group (38.9%). The lower incidence of medical adhesive-related skin injury in the hydrocolloid group compared with the control group corresponded to an absolute risk reduction of 28% and a number needed to treat of 3.6. There were no significant differences among the groups regarding mucosal membrane injury or the duration of enteral nutrition therapy interruption. Conclusions Dedicated securement technologies did not demonstrate superiority over improvised securement methods in preventing displacement or inadvertent removal of the enteral feeding tube. However, the hydrocolloid-based device reduced the medical adhesive-related skin injury incidence, despite showing lower securement durability. These findings highlight a trade-off between mechanical stability and the preservation of skin integrity, reinforcing that the choice of securement technology should be individualized, taking into account the patient's risk profile and the care setting. Registration The trial was registered in the Brazilian Registry of Clinical Trials (ReBEC; RBR-10hr8nzd).